In NMFH1 xenografts, PF3758309 treatment dose-dependently decreased the expression levels of whole-cell PAK1 and nuclear p-PAK1 and correspondingly led to lower Ki-67 index and MVD, hence achieving significant tumor growth inhibition. Here, PAK1 is linked to neoplasm.